Pediatric
Innovation
Hub
Welcome to i4KIDS, the Pediatric Innovation Hub coordinated by Sant Joan de Déu Barcelona Children’s Hospital, which aims to generate a positive social impact and offer solutions adapted to the paediatric population.
This project has been funded by the European Union through the European Regional Development Fund (ERDF). Exp. No. 2021 XARDI 00006
Impact4kids
A Transatlantic Partnership for Pediatric and Maternal Health Innovation
Information
Open call until January, 26, 2025
Looking for all
all Entrepreneurs
Revolutionaries
and Dreamers
who want to change the destiny of health, children and their families
0
Projects identified
0
K€
Financial support provided
0
Members & Associates
Do you have an innovative project or idea? Do not think twice and send it to us! Get in touch with us and we will guide you step by step.
Find out all the projects we are supporting
i4KIDS SERVICES
We offer technical support, analysis and advice to all those innovative projects that can generate an impact and social change in the field of pediatrics and maternity
Expert advice
Viability analysis
Financing
Developing
Clinical investigations
Viability analysis
Financing
Developing
Clinical investigations
Active
Infectious
FUNNY FRIENDS
Interactive game to perform respiratory rehabilitation exercises at home
Enrique del Campo
Active
Orthopedics / Rehabilitation
6MWT+
Six Minute Walk Test Plus (6MWT +) integrates biomechanical sensors into standard exercise
Julita Medina & Arnau Valls
Active
Organizational Innovation
SELTO
Long-lasting central venous access shield
Jordi Torralba & Montserrat Selvas
News & Agenda
Launch of a new acceleration programme, Impact4kids, driven by Impact1 and i4KIDS, which aims to accelerate disruptive technology solutions in foetal, paediatric and maternal health and foster collaboration between innovators on both sides of the Atlantic.
Gate2Brain receives EMA Orphan Drug Designation for pioneering treatment of paediatric brain tumours
The European Medicines Agency (EMA) has awarded Orphan Drug Designation (ODD) to G2B-002, an innovative therapeutic candidate for the treatment of aggressive paediatric brain tumours, including diffuse intrinsic pontine glioma (DIPG) and paediatric glioblastoma (pGBM), developeb by gate2Brain, a spin-off from the Sant Joan de Déu Barcelona Children's Hospital.
After the Pediatric Innovation Day held in Riga last September, i4KIDS celebrates an extraordinary edition in Barcelona of this event of reference in innovation in paediatric, foetal and maternal health, which is consolidated as a meeting and reflection point for the innovative community in paediatrics.